Literature DB >> 26597514

Spontaneous and evoked pain-associated behaviors in a rat model of neuropathic pain respond differently to drugs with different mechanisms of action.

Nobuhito Murai1, Toshihiro Sekizawa2, Takayasu Gotoh2, Tomonari Watabiki2, Masayasu Takahashi2, Shuichiro Kakimoto2, Yuko Takahashi3, Masanobu Iino3, Yukinori Nagakura2.   

Abstract

Given that patients with neuropathic pain suffer a mixture of spontaneous and evoked pain symptoms, we assessed the effects of drugs with different mechanism of action on spontaneous and evoked pain-associated behaviors in a rat model of neuropathic pain induced by chronic constriction injury (CCI) of the sciatic nerve. Frequent aberrant limb movement on the operated side was measured to assess spontaneous pain-associated behavior, and mechanical allodynia and thermal hyperalgesia were evaluated to assess evoked pain-associated behaviors. These three types of behavior were assessed after administration of the following drugs: pregabalin (α2δ-subunit ligand), morphine (μ-opioid receptor agonist), perampanel (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid [AMPA] receptor antagonist), clonidine, dexmedetomidine (α2-adrenoceptor agonists), and diclofenac (non-steroidal anti-inflammatory drug [NSAID]). Pregabalin at an oral dose of 10 or 30mg/kg significantly alleviated frequent aberrant limb movement and mechanical allodynia, but not thermal hyperalgesia. Morphine at a subcutaneous dose of 1 or 3mg/kg significantly improved all three types of behavior. Perampanel at an oral dose of 1mg/kg attenuated only frequent aberrant limb movement. Intraperitoneal administration of clonidine (0.01 or 0.03mg/kg) and dexmedetomidine (0.03mg/kg) significantly improved all three types of behavior, while diclofenac did not relieve any of the behaviors. Pregabalin, clonidine, and dexmedetomidine significantly decreased motor performance at doses close to analgesic doses in the rotarod test. The present study demonstrates that responses to spontaneous and evoked pain symptoms in neuropathic pain condition differ depending on a drug's mechanism of action. The selection and application of drugs according to the specific symptoms would be considered for the medication of patients with neuropathic pain.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic constriction injury; Mechanical allodynia; Neuropathic pain; Spontaneous pain; Thermal hyperalgesia

Mesh:

Substances:

Year:  2015        PMID: 26597514     DOI: 10.1016/j.pbb.2015.11.008

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

1.  Nerve Decompression Improves Spinal Synaptic Plasticity of Opioid Receptors for Pain Relief.

Authors:  To-Jung Tseng; Ming-Ling Yang; Yu-Lin Hsieh; Miau-Hwa Ko; Sung-Tsang Hsieh
Journal:  Neurotox Res       Date:  2017-08-23       Impact factor: 3.911

2.  Synchronized cluster firing, a distinct form of sensory neuron activation, drives spontaneous pain.

Authors:  Qin Zheng; Wenrui Xie; Debora D Lückemeyer; Mark Lay; Xue-Wei Wang; Xintong Dong; Nathachit Limjunyawong; Yaqing Ye; Feng-Quan Zhou; Judith A Strong; Jun-Ming Zhang; Xinzhong Dong
Journal:  Neuron       Date:  2021-11-08       Impact factor: 17.173

3.  Analgesic effects of ASP3662, a novel 11β-hydroxysteroid dehydrogenase 1 inhibitor, in rat models of neuropathic and dysfunctional pain.

Authors:  Tetsuo Kiso; Toshihiro Sekizawa; Hiroshi Uchino; Mina Tsukamoto; Shuichiro Kakimoto
Journal:  Br J Pharmacol       Date:  2018-08-17       Impact factor: 8.739

4.  Sustained analgesic effect of clonidine co-polymer depot in a porcine incisional pain model.

Authors:  Jared T Wilsey; Julie H Block
Journal:  J Pain Res       Date:  2018-04-09       Impact factor: 3.133

5.  Astragalin Alleviates Neuropathic Pain by Suppressing P2X4-Mediated Signaling in the Dorsal Root Ganglia of Rats.

Authors:  Mengke Wang; Xia Cai; Yueying Wang; Shizhen Li; Na Wang; Rui Sun; Jingming Xing; Shangdong Liang; Shuangmei Liu
Journal:  Front Neurosci       Date:  2021-01-11       Impact factor: 4.677

6.  The Acute Antiallodynic Effect of Tolperisone in Rat Neuropathic Pain and Evaluation of Its Mechanism of Action.

Authors:  Péter P Lakatos; Dávid Árpád Karádi; Anna Rita Galambos; Nariman Essmat; Kornél Király; Rudolf Laufer; Orsolya Geda; Zoltán S Zádori; Tamás Tábi; Mahmoud Al-Khrasani; Éva Szökő
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

7.  The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents.

Authors:  Ming-Chi Lai; Ray-Chang Tzeng; Chin-Wei Huang; Sheng-Nan Wu
Journal:  Biomolecules       Date:  2019-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.